T1	PROC 615 619	CICr
#1	AnnotatorNotes T1	C0373595; Creatinine clearance measurement; Laboratory Procedure
T2	CHEM 48 57;69 76	carbonato cálcico
#2	AnnotatorNotes T2	C0006681; calcium carbonate; Pharmacologic Substance · Inorganic Chemical
T3	CHEM 61 76	acetato cálcico
#3	AnnotatorNotes T3	C0717537; calcium acetate; Organic Chemical · Pharmacologic Substance
T4	PROC 423 443	Comparar la eficacia
#4	AnnotatorNotes T4	C1707887; Efficacy Study; Research Activity
T5	DISO 110 125	hiperfosfatemia
#5	AnnotatorNotes T5	C0085681; Hyperphosphatemia (disorder); Disease or Syndrome
T6	DISO 130 142	hipocalcemia
#6	AnnotatorNotes T6	C0020598; Hypocalcemia; Disease or Syndrome
T7	CHEM 159 169	calcitriol
#7	AnnotatorNotes T7	C0006674; calcitriol; Organic Chemical · Pharmacologic Substance · Vitamin | C3714610; Calcitriol Drug Class; Pharmacologic Substance · Vitamin
T8	DISO 183 194	patogénicos
#8	AnnotatorNotes T8	C0699748; Pathogenesis; Pathologic Function
T9	DISO 199 255	hiperparatiroidismo secundario de la insuficiencia renal
#9	AnnotatorNotes T9	C0271847; Hyperparathyroidism due to renal insufficiency; Disease or Syndrome
T10	PROC 298 308	prevención
#10	AnnotatorNotes T10	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T11	PROC 331 367	estudios comparativos de la eficacia
#11	AnnotatorNotes T11	C1707887; Efficacy Study; Research Activity + C1579762; comparative study research; Research Activity
T12	CHEM 386 395	quelantes
#12	AnnotatorNotes T12	C0007974; Chelating Agents; Pharmacologic Substance · Indicator, Reagent, or Diagnostic Aid
T13	CHEM 457 466;477 484	carbonato cálcico
#13	AnnotatorNotes T13	C0006681; calcium carbonate; Pharmacologic Substance · Inorganic Chemical
T14	CHEM 469 484	acetato cálcico
#14	AnnotatorNotes T14	C0717537; calcium acetate; Organic Chemical · Pharmacologic Substance
T15	DISO 502 529	insuficiencia renal crónica
#15	AnnotatorNotes T15	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T16	DISO 601 604	IRC
#16	AnnotatorNotes T16	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T17	CHEM 690 707	carbonato cálcico
#17	AnnotatorNotes T17	C0006681; calcium carbonate; Pharmacologic Substance · Inorganic Chemical
T18	CHEM 745 760	calcio elemento
#18	AnnotatorNotes T18	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T19	CHEM 797 812	acetato cálcico
#19	AnnotatorNotes T19	C0717537; calcium acetate; Organic Chemical · Pharmacologic Substance
T20	CHEM 858 873	calcio elemento
#20	AnnotatorNotes T20	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T21	CHEM 911 918	fósforo
#21	AnnotatorNotes T21	C0031705; phosphorus; Element, Ion, or Isotope
T22	PROC 934 945	seguimiento
#22	AnnotatorNotes T22	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T23	PROC 975 1011	determinaciones analíticas de calcio
T24	PROC 1040 1051	F, alcalina
#23	AnnotatorNotes T24	C0201850; Alkaline phosphatase measurement; Laboratory Procedure
T25	PROC 1152 1162	F alcalina
#24	AnnotatorNotes T25	C0201850; Alkaline phosphatase measurement; Laboratory Procedure
T26	PROC 1054 1058	ClCr
#25	AnnotatorNotes T26	C0373595; Creatinine clearance measurement; Laboratory Procedure
T27	PROC 1129 1133	ClCr
#26	AnnotatorNotes T27	C0373595; Creatinine clearance measurement; Laboratory Procedure
T28	CHEM 1173 1179	calcio
#27	AnnotatorNotes T28	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T29	ANAT 1180 1186	sérico
#28	AnnotatorNotes T29	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T30	CHEM 1251 1268	carbonato cálcico
#29	AnnotatorNotes T30	C0006681; calcium carbonate; Pharmacologic Substance · Inorganic Chemical
T31	CHEM 1344 1359	acetato cálcico
#30	AnnotatorNotes T31	C0717537; calcium acetate; Organic Chemical · Pharmacologic Substance
T32	PROC 1374 1381	fósforo
#31	AnnotatorNotes T32	C0202178; Phosphorus measurement; Laboratory Procedure
T33	CHEM 1480 1486	calcio
#32	AnnotatorNotes T33	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T34	CHEM 1586 1595;1609 1616	carbonato cálcico
#33	AnnotatorNotes T34	C0006681; calcium carbonate; Pharmacologic Substance · Inorganic Chemical
T35	CHEM 1601 1616	acetato cálcico
#34	AnnotatorNotes T35	C0717537; calcium acetate; Organic Chemical · Pharmacologic Substance
T36	CHEM 1668 1675	fósforo
#35	AnnotatorNotes T36	C0031705; phosphorus; Element, Ion, or Isotope
T37	CHEM 1769 1786	carbonato cálcico
#36	AnnotatorNotes T37	C0006681; calcium carbonate; Pharmacologic Substance · Inorganic Chemical
T38	CHEM 1807 1813	calcio
#37	AnnotatorNotes T38	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T39	CHEM 1855 1870	acetato cálcico
#38	AnnotatorNotes T39	C0717537; calcium acetate; Organic Chemical · Pharmacologic Substance
T40	CHEM 1878 1893	acetato cálcico
#39	AnnotatorNotes T40	C0717537; calcium acetate; Organic Chemical · Pharmacologic Substance
T41	CHEM 1654 1663	quelantes
#40	AnnotatorNotes T41	C0007974; Chelating Agents; Pharmacologic Substance · Indicator, Reagent, or Diagnostic Aid
T42	DISO 148 169	déficit de calcitriol
T43	ANAT 250 255	renal
#41	AnnotatorNotes T43	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T44	CHEM 272 279	fósforo
#42	AnnotatorNotes T44	C0031705; phosphorus; Element, Ion, or Isotope
T45	ANAT 516 521	renal
#43	AnnotatorNotes T45	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T46	PROC 900 918	dieta baja fósforo
#44	AnnotatorNotes T46	C0452351; Low phosphate diet; Therapeutic or Preventive Procedure
T47	CHEM 1005 1011	calcio
#45	AnnotatorNotes T47	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T48	PROC 1014 1021	fósforo
#46	AnnotatorNotes T48	C0202178; Phosphorus measurement; Laboratory Procedure
T49	PROC 1035 1038	PTH
#47	AnnotatorNotes T49	C0202159; Parathyroid hormone measurement; Laboratory Procedure
T50	PROC 1135 1141	calcio
#48	AnnotatorNotes T50	C0201925; Calcium measurement; Laboratory Procedure
T51	PROC 1143 1150	fósforo
#49	AnnotatorNotes T51	C0202178; Phosphorus measurement; Laboratory Procedure
T52	PROC 1165 1168	PTH
#50	AnnotatorNotes T52	C0202159; Parathyroid hormone measurement; Laboratory Procedure
T53	PROC 1173 1186	calcio sérico
#51	AnnotatorNotes T53	C0728876; Serum calcium measurement; Laboratory Procedure
T54	PROC 1469 1486	niveles de calcio
#52	AnnotatorNotes T54	C0201925; Calcium measurement; Laboratory Procedure
T55	PROC 1488 1506	Fosfatasa alcalina
#53	AnnotatorNotes T55	C0201850; Alkaline phosphatase measurement; Laboratory Procedure
T56	PROC 1509 1512	PTH
#54	AnnotatorNotes T56	C0202159; Parathyroid hormone measurement; Laboratory Procedure
T57	CHEM 1748 1755	fósforo
#55	AnnotatorNotes T57	C0031705; phosphorus; Element, Ion, or Isotope
T58	CHEM 1976 1983	fósforo
#56	AnnotatorNotes T58	C0031705; phosphorus; Element, Ion, or Isotope
T59	Time 80 91	prediálisis
T60	Neg_cue 320 322	No
T61	Time 399 410	prediálisis
T62	LIVB 488 497	pacientes
#57	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T63	Duration 522 529	crónica
#58	AnnotatorNotes T63	C0205191; chronic; Temporal Concept
T64	Time 539 550	prediálisis
T65	LIVB 587 596	pacientes
#59	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T68	LIVB 668 677	pacientes
#60	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T69	Dose 719 727	2.500 mg
T70	Frequency 727 731	/día
T71	Dose 733 741	1.000 mg
T72	LIVB 775 784	pacientes
#61	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group
T73	Dose 824 832	1.000 mg
T74	Dose 848 854	254 mg
T75	Duration 953 961	24 meses
T76	Frequency 1022 1032	trimestral
T77	Frequency 1059 1073	semestralmente
T66	CHEM 37 44	fósforo
#62	AnnotatorNotes T66	C0031705; phosphorus; Element, Ion, or Isotope
A1	Assertion T11 Negated
T67	Neg_cue 1943 1946	sin
T78	Observation 1947 1962	perder eficacia
A2	Assertion T78 Negated
R1	Negation Arg1:T67 Arg2:T78	
T79	Neg_cue 1209 1211	no
T80	Quantifier_or_Qualifier 1212 1234	de forma significativa
A3	Assertion T80 Negated
#63	AnnotatorNotes T80	C0750502; Significant; Idea or Concept
R2	Negation Arg1:T79 Arg2:T80	
T81	Neg_cue 1513 1515	no
T82	CONC 1516 1530	se modificaron
A4	Assertion T82 Negated
#64	AnnotatorNotes T82	C0443172; Changed status; Quantitative Concept
R3	Negation Arg1:T81 Arg2:T82	
T83	CONC 1315 1328	modificándose
A5	Assertion T83 Negated
#65	AnnotatorNotes T83	C0443172; Changed status; Quantitative Concept
T84	Neg_cue 1312 1314	no
R4	Negation Arg1:T84 Arg2:T83	
R5	Negation Arg1:T60 Arg2:T11	
#66	AnnotatorNotes T78	C5209257; Reduced drug efficacy; Finding
T85	Quantifier_or_Qualifier 1963 1983	quelante del fósforo
A6	Assertion T85 Negated
R6	Negation Arg1:T67 Arg2:T85	
R7	Has_Quantifier_or_Qualifier Arg1:T78 Arg2:T85	
T86	Observation 17 23	efecto
#67	AnnotatorNotes T86	C1518681; Outcome of Therapy; Finding (?)
T87	Quantifier_or_Qualifier 24 44	quelante del fósforo
R8	Has_Quantifier_or_Qualifier Arg1:T86 Arg2:T87	
R11	Overlap Arg1:T3 Arg2:T59	
R12	Causes Arg1:T3 Arg2:T86	
R9	Overlap Arg1:T2 Arg2:T59	
R13	Causes Arg1:T2 Arg2:T86	
R10	Location_of Arg1:T43 Arg2:T9	
R14	Overlap Arg1:T42 Arg2:T9	
R15	Overlap Arg1:T6 Arg2:T9	
R16	Overlap Arg1:T5 Arg2:T9	
R17	Overlap Arg1:T12 Arg2:T61	
R18	Experiences Arg1:T62 Arg2:T13	
R19	Experiences Arg1:T62 Arg2:T14	
R20	Experiences Arg1:T62 Arg2:T15	
R21	Location_of Arg1:T45 Arg2:T15	
R22	Has_Duration_or_Interval Arg1:T15 Arg2:T63	
R23	Overlap Arg1:T15 Arg2:T64	
R24	Overlap Arg1:T13 Arg2:T64	
R25	Overlap Arg1:T14 Arg2:T64	
T88	Quantifier_or_Qualifier 530 538	avanzada
#68	AnnotatorNotes T88	C0205179; Advanced phase; Qualitative Concept
R26	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T88	
T89	Quantifier_or_Qualifier 605 613	avanzada
#69	AnnotatorNotes T89	C0205179; Advanced phase; Qualitative Concept
R27	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T89	
R28	Experiences Arg1:T65 Arg2:T16	
R29	Experiences Arg1:T65 Arg2:T1	
R30	Experiences Arg1:T68 Arg2:T17	
R31	Has_Dose_or_Strength Arg1:T17 Arg2:T69	
R32	Has_Frequency Arg1:T17 Arg2:T70	
R33	Experiences Arg1:T68 Arg2:T18	
R34	Has_Dose_or_Strength Arg1:T18 Arg2:T71	
R35	Has_Frequency Arg1:T18 Arg2:T70	
R36	Experiences Arg1:T72 Arg2:T19	
R37	Has_Dose_or_Strength Arg1:T19 Arg2:T73	
R38	Experiences Arg1:T72 Arg2:T20	
R39	Has_Dose_or_Strength Arg1:T20 Arg2:T74	
R40	Has_Duration_or_Interval Arg1:T22 Arg2:T75	
R41	Has_Frequency Arg1:T23 Arg2:T76	
R42	Has_Frequency Arg1:T48 Arg2:T76	
R43	Has_Frequency Arg1:T49 Arg2:T77	
R44	Has_Frequency Arg1:T24 Arg2:T77	
R45	Has_Frequency Arg1:T26 Arg2:T77	
R46	Location_of Arg1:T29 Arg2:T53	
T90	Observation 1173 1200	calcio sérico se incrementó
#70	AnnotatorNotes T90	C0595928; Serum calcium increased; Finding
R47	Before Arg1:T30 Arg2:T90	
T91	Observation 1374 1391	fósforo disminuyó
#71	AnnotatorNotes T91	C0877517; Blood phosphorus decreased; Finding (?)
R49	Before Arg1:T30 Arg2:T91	
R53	Before Arg1:T31 Arg2:T53	
T92	Quantifier_or_Qualifier 1654 1675	quelantes del fósforo
T93	Quantifier_or_Qualifier 1735 1755	quelante del fósforo
T94	Observation 1728 1734	efecto
#72	AnnotatorNotes T94	C1518681; Outcome of Therapy; Finding (?)
R56	Has_Quantifier_or_Qualifier Arg1:T94 Arg2:T93	
T95	Dose 1798 1803;1814 1835	dosis cuatro veces superior
R57	Has_Dose_or_Strength Arg1:T38 Arg2:T95	
T96	Observation 1925 1941	hipercalcemiante
#73	AnnotatorNotes T96	C0595928; Serum calcium increased; Finding (?)
R58	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T96	
R59	Before Arg1:T40 Arg2:T78	
R60	Overlap Arg1:T86 Arg2:T59	
R61	Causes Arg1:T37 Arg2:T94	
R62	Causes Arg1:T39 Arg2:T94	
R63	Causes Arg1:T38 Arg2:T94	
T97	Result_or_Value 620 629	21 ml/min
R64	Has_Result_or_Value Arg1:T1 Arg2:T97	
#74	AnnotatorNotes T23	C0201925; Calcium measurement; Laboratory Procedure
A7	Experiencer T62 Patient
A8	Experiencer T65 Patient
A9	Experiencer T68 Patient
A10	Experiencer T72 Patient
R48	Has_Result_or_Value Arg1:T53 Arg2:T90	
